Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sadot Group | SDOT | Nov 21, 2024 | 3.53 | -4.59 |
Safe & Green Holdings | SGBX | Nov 21, 2024 | 0.51 | +0.20 |
Safe And Green Development | SGD | Nov 21, 2024 | 1.79 | -1.11 |
Safe Bulkers | SB | Nov 21, 2024 | 4.12 | -2.60 |
Safe Bulkers Pref C | SB-C | Nov 21, 2024 | 25.51 | +0.20 |
Safe Bulkers Pref D | SB-D | Nov 21, 2024 | 25.76 | +0.63 |
Safe Pro Group | SPAI | Nov 21, 2024 | 4.47 | 0.00 |
Safehold | SAFE | Nov 21, 2024 | 20.46 | +0.15 |
Safety Insurance Group | SAFT | Nov 21, 2024 | 84.77 | +1.33 |
Safety Shot | SHOT | Nov 21, 2024 | 0.87 | -3.51 |
SAG Holdings Limited - Ordinary Shares | SAG | Nov 21, 2024 | 2.69 | 0.00 |
Saga Communications A | SGA | Nov 21, 2024 | 12.62 | +3.19 |
Sage Therapeutics | SAGE | Nov 21, 2024 | 4.85 | -1.22 |
Sagimet Biosciences | SGMT | Nov 21, 2024 | 4.50 | -0.44 |
SAI.TECH Global | SAI | Nov 21, 2024 | 0.75 | 0.00 |
Saia | SAIA | Nov 21, 2024 | 549.19 | +3.62 |
SAIHEAT A | SAIH | Nov 21, 2024 | 1.02 | 0.00 |
Salarius Pharmaceuticals | SLRX | Nov 21, 2024 | 1.46 | +4.29 |
Salesforce | CRM | Nov 21, 2024 | 335.78 | +3.09 |
Sally Beauty | SBH | Nov 21, 2024 | 12.97 | -1.22 |
Samfine Creation Group | SFHG | Nov 21, 2024 | 13.10 | 0.00 |
Samsara A | IOT | Nov 21, 2024 | 54.88 | +4.28 |
San Juan Basin Royalty Trust Unit | SJT | Nov 21, 2024 | 4.04 | +5.48 |
Sana Biotechnology | SANA | Nov 21, 2024 | 2.35 | -7.11 |
Sanara MedTech | SMTI | Nov 21, 2024 | 37.32 | +0.11 |
SandRidge Energy | SD | Nov 21, 2024 | 11.75 | +0.43 |
Sandstorm Gold | SAND | Nov 21, 2024 | 5.80 | +2.11 |
Sandy Spring Bancorp | SASR | Nov 21, 2024 | 37.17 | +1.64 |
Sangamo Therapeutics | SGMO | Nov 21, 2024 | 1.96 | +0.51 |
Sangoma Technologies | SANG | Nov 21, 2024 | 6.10 | -2.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.